Proximal Femur FracturesNCT07716358
Comparison Of Preoperative Ultrasound Guided Fascia Iliaca Block Versus Femoral Nerve Block for Proximal Femur Fractures Before Positioning for Spinal Anaesthesia
A study testing Femoral Nerve Block and Fascia Iliaca Nerve Block in people with Proximal Femur Fractures and Nerve Block Assessment, run by Sahara Medical College Narowal Pakistan at 1 site in Pakistan.
Trial summary
Proximal femur fractures are among the most painful orthopedic injuries Adequate analgesia is essential to facilitate positioning for spinal anesthesia, reduce opioid requirements, and minimize related complications. Read more about this study
- Who is it for?
- Ages 20 to 70 years
- Conditions the study is for
- Proximal Femur Fractures, Nerve Block Assessment
- What is being tested?
- Femoral Nerve Block and Fascia Iliaca Nerve Block
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 84 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Jan 2026to 30 Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- ASA I\&II status patients coming for proximal femur fracture surgery
Who cannot join
- Patients with history of neurological disease (Alzheimer, dementia),
- Patients with known contraindication to regional anaesthesia (e.g., signs of infection at site of block, coagulation abnormality i.e. INR >1.55, platelet count <80,000)
- Patients with ASA III and IV status and patients with Known allergy to the study drug were excluded from study.
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Sughra Shafi Medical Complex
Chak Ninety-five North Branch, Punjab Province, 51600
About this study
Proximal femur fractures are among the most painful orthopedic injuries Adequate analgesia is essential to facilitate positioning for spinal anesthesia, reduce opioid requirements, and minimize related complications. The aim of study to compare the analgesic efficacy of preoperative ultrasound-guided Fascia Iliac Block Versus and Femoral Nerve Block in patients with proximal femur fractures prior to positioning for spinal anesthesia.
- Conditions
- Proximal Femur Fractures, Nerve Block Assessment
- Being tested
- Femoral Nerve Block, Fascia Iliaca Nerve Block
- Keywords
- Femoral Nerve block, Fascia Iliac Compartment Block, visual analogue scale
- Medical subject headings
- Proximal Femoral Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Femoral Nerve BlockProcedure or surgery
FNB was carried out as follows: the linear probe was kept in a "in line plane" approach to identify the femoral artery under ultrasound guidance. The triangular, hyperechoic femoral nerve was identified as being situated lateral to the femoral artery. The femoral artery was positioned next to an insulated 22 G needle. Once the needle tip was located and a negative blood aspiration was obtained, a little amount of local anesthetic (injection bupivacaine 0.25%) was administered. The remaining drug volume was injected based on weight (0.5 ml/kg) once the local anesthetic distribution was observed
Fascia Iliaca Nerve BlockProcedure or surgery
The FICB was administered as described. We found the psoas muscle lateral to the femoral nerve. The iliacus fascia, which extends deep into the fascia Lata, covers it. Consequently, a double pop was felt after inserting the needle until it was between the psoas muscle and the fascia iliaca. As with the previously described method, 1 mL of the local aesthetic solution was injected, and following a negative blood aspiration, the medication disseminated beneath the fascia iliaca.
| Study group | Role | What they receive |
|---|---|---|
| Group A Participants who received Ultrasound Guided Femoral Nerve Block | Experimental | Participants in group-A were 42 which were assigned randomly and Femoral Nerve Block was done before spinal anaesthesia. Receives: Procedure: Femoral Nerve Block |
| Group B Participants who received Ultrasound Guided Fascia Iliaca Block | Active comparator | Participants in group- B were 42 which were assigned randomly and Fascia Iliaca Block was done before spinal anaesthesia. Receives: Procedure: Fascia Iliaca Nerve Block |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Control
In patients with proximal femur fractures pain assessment was done baseline before blocks and at five minutes after blocks administration. Pain control assessment was done based on Visual Analogue Scale from 0-10.
Measured: 05 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jul 2026
- Study start1 Jan 2026
- Primary completion30 Jun 2026
- Study completion30 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Proximal Femur FracturesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 84 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sahara Medical College Narowal Pakistan
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr Rafia Kousar, Sahara Medical College Narowal Pakistan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07716358
- Sponsor's protocol ID
- 12
- Status last verified
- Jul 2026
- First submitted
- 9 Jul 2026
- Last updated
- 21 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison Of Preoperative Ultrasound Guided Fascia Iliaca Block Versus Femoral Nerve Block for Proximal Femur Fractures Before Positioning for Spinal Anaesthesia
- ClinicalTrials.gov ID
- NCT07716358
- Acronym / sponsor ID
- 12
- Conditions
- Proximal Femur Fractures, Nerve Block Assessment
- Keywords
- Femoral Nerve block, Fascia Iliac Compartment Block, visual analogue scale
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 84 participants (actual)
- Lead sponsor
- Sahara Medical College Narowal PakistanUniversity, hospital or other
- Study start
- 1 Jan 2026 (actual)
- Primary completion
- 30 Jun 2026 (actual)
- Study completion
- 30 Jun 2026 (actual)
- First posted
- 21 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Proximal femur fractures are among the most painful orthopedic injuries Adequate analgesia is essential to facilitate positioning for spinal anesthesia, reduce opioid requirements, and minimize related complications. The aim of study to compare the analgesic efficacy of preoperative ultrasound-guided Fascia Iliac Block Versus and Femoral Nerve Block in patients with proximal femur fractures prior to positioning for spinal anesthesia.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A Participants who received Ultrasound Guided Femoral Nerve Block | Experimental | Procedure: Femoral Nerve BlockParticipants in group-A were 42 which were assigned randomly and Femoral Nerve Block was done before spinal anaesthesia. |
| Group B Participants who received Ultrasound Guided Fascia Iliaca Block | Active comparator | Procedure: Fascia Iliaca Nerve BlockParticipants in group- B were 42 which were assigned randomly and Fascia Iliaca Block was done before spinal anaesthesia. |
Who may qualify
- Ages
- 20 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- ASA I\&II status patients coming for proximal femur fracture surgery
Key exclusion criteria (3 listed)
- Patients with history of neurological disease (Alzheimer, dementia),
- Patients with known contraindication to regional anaesthesia (e.g., signs of infection at site of block, coagulation abnormality i.e. INR >1.55, platelet count <80,000)
- Patients with ASA III and IV status and patients with Known allergy to the study drug were excluded from study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Femoral Nerve BlockFNB was carried out as follows: the linear probe was kept in a "in line plane" approach to identify the femoral artery under ultrasound guidance. The triangular, hyperechoic femoral nerve was identified as being situated lateral to the femoral artery. The femoral artery was positioned next to an insulated 22 G needle. Once the needle tip was located and a negative blood aspiration was obtained, a little amount of local anesthetic (injection bupivacaine 0.25%) was administered. The remaining drug volume was injected based on weight (0.5 ml/kg) once the local anesthetic distribution was observed | Procedure or surgery | Group A Participants who received Ultrasound Guided Femoral Nerve Block |
| Fascia Iliaca Nerve BlockThe FICB was administered as described. We found the psoas muscle lateral to the femoral nerve. The iliacus fascia, which extends deep into the fascia Lata, covers it. Consequently, a double pop was felt after inserting the needle until it was between the psoas muscle and the fascia iliaca. As with the previously described method, 1 mL of the local aesthetic solution was injected, and following a negative blood aspiration, the medication disseminated beneath the fascia iliaca. | Procedure or surgery | Group B Participants who received Ultrasound Guided Fascia Iliaca Block |
Primary outcome
Pain Control
Time frame: 05 minutes
In patients with proximal femur fractures pain assessment was done baseline before blocks and at five minutes after blocks administration. Pain control assessment was done based on Visual Analogue Scale from 0-10.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Proximal Femur Fractures
Enrolling by invitationObservational study
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
Osteoporosis
Not yet recruiting
X-BS Ortho Bone Graft Study
Orthopedic Disorder, Trauma Injury
RecruitingPhase 2
CITADEL: Effectiveness of CITicoline in Preventing Cognitive Decline After DELirium
Cognitive Decline, Delirium
Recruiting
A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
Femoral Fracture
Recruiting
Pericapsular Nerve Group Block Versus Femoral Nerve Block Study
Hip Fractures
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Femoral Nerve Block and Fascia Iliaca Nerve Block in people with Proximal Femur Fractures and Nerve Block Assessment, run by Sahara Medical College Narowal Pakistan at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Control (time frame: 05 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026.